Back to Results
First PageMeta Content
Antibody / Monoclonal antibodies / B cell / Library / Antigen / Polyclonal antibodies / Symphogen / Immune system / Biology / Anatomy


MORPHODOMA® Technology: Enhancing Antibody Titers
Add to Reading List

Document Date: 2011-02-26 01:00:51


Open Document

File Size: 379,27 KB

Share Result on Facebook

City

Exton / /

Company

Morphotek Inc. / /

Continent

America / /

Currency

USD / /

/

Facility

Generate library / stable MORPHODOMA / /

IndustryTerm

technology results / genomic and proteomic tools / mammalian systems / chemical mutagens / gene products / gene product / antibody technologies / manufacturing cell hosts / alternative solutions / biopharmaceutical market / mammalian cell-based systems / machinery / treatment for human disease / manufacturing cell line / heavy chain / morphogene product / antibody products / scaleable manufacturing / /

MedicalCondition

colorectal cancer / hereditary non-polyposis / Vogelstein B. Mismatch repair deficiency / human disease / /

Organization

American Cancer Society / /

Person

Wolfgang Ebel / Qimin Chao / J. Bradford Kline / Nicholas C. Nicolaides Disclaimer / Eric L. Routhier / George Miller / Nicholas C. Nicolaides / Philip M. Sass / Luigi Grasso / /

Position

CEO / representative / COO / Vice President of R. & D. / /

Product

Avastin / Erbitux / Xolair / /

ProvinceOrState

Pennsylvania / /

Technology

gene cloning / antibody technologies / gene amplification / DNA Chip / Antibodies / biotechnology / high-throughput screening / recombination / /

URL

www.phrma.org/newmedicines/resources/2002 / www.cancer.org / /

SocialTag